Reconstitution of protection against Aspergillus infection in chronic granulomatous disease (CGD).
Remijsen
Quinten
Q
Vandenabeele
Peter
P
Willems
Jean
J
Kuijpers
Taco W
TW
D000935:Antifungal Agents / Q000378:metabolism; D001228:Aspergillosis / Q000209:etiology / Q000235:genetics / Q000378:metabolism / Q000517:prevention & control*; D001233:Aspergillus nidulans; D002634:Chemotaxis, Leukocyte / Q000235:genetics* / Q000276:immunology; D002648:Child; D015316:Genetic Therapy / Q000379:methods; D006105:Granulomatous Disease, Chronic / Q000150:complications / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D006801:Humans; D008297:Male; D009504:Neutrophils / Q000378:metabolism / Q000502:physiology*
D000935:Antifungal Agents